SAN DIEGO, Oct. 24, 2017 /PRNewswire/ -- Access Scientific announced today that the POWERWAND™ midline catheter now has over 23,000 catheter days of scientific data without a single catheter-related ...
BILLERICA, Mass.--(BUSINESS WIRE)--Access Vascular, Inc. (AVI), a leader in tackling critical vascular access challenges with its advanced hydrophilic biomaterial technology, today announced findings ...
Midline catheters and vascular access devices (VADs) play a pivotal role in modern clinical practice by offering less invasive alternatives to central venous access. Midline catheters, which are ...
The incidence of catheter-related bloodstream infections was low in patients with midline vs peripherally inserted central catheters, but the use of midline catheters was associated with increased ...
Vancomycin was associated with a higher rate of major device complications in patients discharged with midline catheters for outpatient parenteral antimicrobial therapy (OPAT), a retrospective ...
BEDFORD, Mass.--(BUSINESS WIRE)--Access Vascular, Inc. today announced FDA clearance of its HydroMID™ midline catheter. HydroMID, which is made of Access Vascular’s proprietary biomaterial that has ...
DELRAY BEACH, FL, UNITED STATES, May 6, 2025 /EINPresswire.com/ -- SkyDance Vascular, Inc. (SkyDance) today announced it has received 510(k) clearance from the U.S ...
Guidelines recommend against use of midline catheters for vancomycin-based outpatient parenteral antimicrobial therapy (OPAT), but evidence supporting the guidance is limited. This retrospective study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results